𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of neoadjuvant chemotherapy on MDR1 and MRP gene expression in primary breast cancer

✍ Scribed by Xing-e Liu; Xiao-dong Sun; Jin-min Wu


Publisher
Chinese Anti-Cancer Association
Year
2004
Tongue
English
Weight
375 KB
Volume
16
Category
Article
ISSN
1000-9604

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Future prospects of neoadjuvant chemothe
✍ Hwei-Chung Wang; Su-Shun Lo πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 689 KB

Neoadjuvant chemotherapy in breast cancer was developed in the 1970s and is now used in patients with locally advanced or early resectable breast cancer. Early administration of systemic chemotherapy before local treatment in locally advanced breast cancer and early resectable breast cancer is inten

Investigation of MRP-1 protein and MDR-1
✍ Annemarie Larkin; Lorraine O'Driscoll; Susan Kennedy; Rachel Purcell; Elizabeth πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 242 KB

## Abstract The efficacy of breast cancer treatment is limited by the development of resistance to various chemotherapeutic agents. We conducted a retrospective study of the expression of 2 drug resistance efflux pumps, MRP‐1 and MDR‐1 Pgp, in 177 invasive breast carcinomas. Immunohistochemical exp

High rate of MDR-1 and heterogeneous pat
✍ Manel Esteller; Josep M. Martinez-Palones; Angel GarcΓ­a; Jordi Xercavins; Jaume πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 908 KB

The present study was undertaken to determine the pattern of expression of 2 molecular markers of multidrug resistance, the MDR-I and MRP genes, in endometrial carcinomas from 50 untreated patients using a PCR semi-quantitative assay. In addition, PCR analysis of MDR-I and MRP gene amplification was